American Kidney Fund Announces 2023 Class of Corporate Members Supporting the Fight Against Kidney Disease
March 07, 2023 09:54 ET
|
American Kidney Fund
ROCKVILLE, Md., March 07, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced its 2023 Class of Corporate Members, strategic partners in its Corporate Membership Program....
Global Renal Biomarkers Technologies and Market Analysis Report 2022: There is a Gap for an Ideal Renal Biomarker - Market Revenues 2019-2021, Estimates for 2022, and CAGR Projections through 2027
March 02, 2023 05:58 ET
|
Research and Markets
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "Renal Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The report examines recent...
Kidney Month: A Time of Unity and Action on Behalf of 37 Million Living with Kidney Disease
February 28, 2023 09:33 ET
|
American Kidney Fund
ROCKVILLE, Md., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Tomorrow, the American Kidney Fund (AKF) will kick off the first day of Kidney Month, which raises awareness of kidney disease, a life-altering...
American Kidney Fund Releases 2023 Living Donor Protection Report Card, Highlighting Progress Toward Better Laws to Support Living Organ Donation
February 23, 2023 07:00 ET
|
American Kidney Fund
ROCKVILLE, Md., Feb. 23, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today released its third annual State of the States: Living Donor Protection Report Card. The 2023 Report Card...
Eledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
February 08, 2023 16:05 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, Chief Executive Officer, will present at the...
American Kidney Fund Announces Support for Two Rare Kidney Disease Education Campaigns
January 24, 2023 09:00 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 24, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced sponsorship from Novartis Pharmaceuticals Corporation (Novartis) for education and awareness...
Eledon Pharmaceuticals Provides Business and Pipeline Updates
January 09, 2023 08:31 ET
|
Eledon Pharmaceuticals, Inc.
Company plans to prioritize and focus resources on the advancement of tegoprubart in kidney transplantation Continued enrollment in open-label Phase 1b kidney transplant trial with initial data...
C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
December 21, 2022 16:05 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path) announced on December 20, 2022, that its Transplant Therapeutic Consortium (TTC) received a qualification opinion...
American Kidney Fund Thanks Amgen for its Champion Level 2022 Corporate Membership
December 13, 2022 09:00 ET
|
American Kidney Fund
ROCKVILLE, Md., Dec. 13, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today expressed its appreciation for Amgen’s participation in the 2022 class of its Corporate Membership Program as a...
Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
November 14, 2022 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Received FDA clearance of IND application to evaluate tegoprubart in a Phase 2 trial for the prevention of rejection in patients receiving a kidney transplant Dosed initial two patients in ex-U.S....